Grants > Developing New Drugs to Lower Eye Pressure in Glaucoma
Updated On: Jul 30, 2025
National Glaucoma Research Grant
Developing New Drugs to Lower Eye Pressure in Glaucoma
Controlling Eye Pressure in New Ways
About the Research Project
Program
National Glaucoma Research
Award Type
Bold Ideas initiatives
Award Amount
$650,000
Active Dates
March 31, 2021 - June 30, 2024
Grant ID
CG2020003
Acknowledgement
Part C of Joint Research Award for a Collaborative Interinstitutional Grant.
Co-Principal Investigator(s)
Joseph Sherwood, PhD, Imperial College London (UK)
Goals
Our research has identified a particular cell type (Schlemm’s canal cells) that regulate eye pressure by controlling the drainage of aqueous humor from the eye. In this project, we will develop and apply novel screening technologies to identify new drugs to lower eye pressure by improving aqueous humor drainage across Schlemm’s canal cells.
Related Grants
National Glaucoma Research
Developing a New Glaucoma Treatment That Avoids Daily Drops
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Gavin Roddy, MD, PhD
Current Organization
Mayo Clinic, Rochester
National Glaucoma Research
Novel Mechanisms to Regulate Eye Pressure
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Colleen McDowell, PhD
Current Organization
University of Wisconsin-Madison
National Glaucoma Research
The Role of Microtubules in Glaucomatous Schlemm’s Canal Mechanobiology
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Haiyan Li, PhD
Current Organization
Georgia Institute of Technology